Record Display for the EPA National Library Catalog


Main Title Proposed development document for new source performance standards for the pharmaceutical manufacturing point source category.
CORP Author Environmental Protection Agency, Washington, DC. Effluent Guidelines Div.
Publisher Effluent Guidelines Division, Office of Water, U.S. Environmental Protection Agency,
Year Published 1983
Report Number EPA 440/1-83/084-b
Stock Number PB93-206969
OCLC Number 10329168
Subjects Effluent quality--United States ; Drug factories--Environmental aspects--United States ; Water pollution control industry--United States
Additional Subjects Drug industry ; Industrial waste treatment ; Chemical effluents ; Pollutions regulations ; Water pollution control ; Water pollution abatement ; Waste water ; Point sources ; Industrial plants ; Water pollution sampling ; Water pollution economics ; Economic impact ; Pretreatment ; Treatment technology ; BAT(Best Available Technology)
Internet Access
Description Access URL
Library Call Number Additional Info Location Last
EJBD ARCHIVE EPA 440-1-83-084b Headquarters Library/Washington,DC 08/27/2014
EJBD  EPA 440-1-83-084b Headquarters Library/Washington,DC 03/27/2017
ERAD  EPA 440/1-83-084b Region 9 Library/San Francisco,CA 10/22/2012
ESAD  EPA 440-1-83-084B Region 10 Library/Seattle,WA 03/23/2010
NTIS  PB93-206969 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation vii, 61 pages ; 28 cm
Pharmaceutical plants manufacture biological products, medicinal chemicals, botanical products, and other pharmaceutical products. EPA identified 466 operating facilities involved in the manufacture of pharmaceutical products. Most of the pharmaceutical industry is located in the eastern half of the United States. The most prevalent manufacturing operation in the industry is the formulating, mixing, and compounding operation; batch-type production is the most common type of manufacturing technique for this industry. The wastewaters produced and discharged by the pharmaceutical industry are very diverse. Plant size, products, processes, and materials to which wastewater is exposed vary greatly. Additionally, the ratio of finished product to the quantity of raw materials, solvents, and other processing materials is generally very low.
Cover title: Development document for effluent limitations guidelines and standards for the pharmaceuticals manufacturing. Distributed to depository libraries in microfiche. "September 1983." Includes bibliographical references. "EPA 440/1-83/084-b"--Cover.